Associate Professor, Medicine, UCLA School of Medicine
Endocrinology
Dr. Run Yu, MD
|
|
Give Review
Doctor Run Yu, MD works in the field of Endocrinology. He studied medicine at Peking Union Medical College. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". is also a published doctor. He has 77 paper published. The most recent paper is: TEMPORAL ADIPOSIS DOLOROSA. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- TEMPORAL ADIPOSIS DOLOROSA.
- Animal models of spontaneous pancreatic neuroendocrine tumors.
- Elusive liver factor that causes pancreatic alpha cell hyperplasia: A review of literature.
- Black Adrenal adenoma causing Cushing's syndrome: 40 years ago and today.
- FOCAL HEPATIC STEATOSIS AROUND MALIGNANT INSULINOMA.
- Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?
- The Dr Pheo Blog and virtual counselling for rare Diseases.
- Adult-onset idiopathic isolated central Hypothyroidism: a case report and literature review.
- A protracted and aggressive variant of lymphocytic hypophysitis with mammillary body involvement and cognitive dysfunction.
- Insignificant medium-term Vitamin D status change after 25-hydroxyVitamin D testing in a large managed care population.
- alpha-Internexin: a novel biomarker for pancreatic neuroendocrine tumor aggressiveness.
- Multiple endocrine neoplasia Type 2A in an Iranian family: clinical and genetic studies.
- Subacute thyroiditis metamorphosing into Graves' Disease.
- Commentary on "Surge in US Outpatient Vitamin D Deficiency Diagnoses: National Ambulatory Medical Care Survey Analysis".
- Too little or too much corticosteroid? Coexisting Adrenal insufficiency and Cushing's syndrome from chronic, intermittent use of intranasal betamethasone.
- Exocrine pancreas hyperplasia without dysplasia in glucagon receptor knockout mice.
- Hypercalcemia: from a rainy city to a sunny desert.
- Pancreatic α-Cell Hyperplasia: Facts and Myths.
- Clinical utility of FDG-PET for diagnosis of Adrenal mass: a large single-center experience.
- Unsuspected Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)-Positive Pancreatic Lesions: Prevalence and Significance.
- Animal models and cell lines of pancreatic neuroendocrine tumors.
- Humoral hypercalcemia of malignancy caused by paraThyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases.
- Mixed acinar-endocrine carcinoma of the pancreas: new clinical and pathological features in a contemporary series.
- Atypical de Quervain's Thyroiditis masquerading as papillary Thyroid cancer.
- Perioperative management of pheochromocytoma: the heart of the issue.
- Radioembolization for treatment of liver metastases from neuroendocrine tumors: correlation with imaging and biomarkers.
- Glucagon cell adenomatosis without glucagon receptor mutation.
- Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment.
- Glucagon receptor is required for long-term survival: a natural history study of the Mahvash Disease in a murine model.
- Ghost carcinoid in a patient with 120-fold elevated 5-hydroxyindoacetic acid.
- Cardiac arrest in a patient with asthma: role of hemorrhagic pheochromocytoma discovered at autopsy.
- FDG PET/CT as a prognostic test after 90Y radioembolization in patients with metastatic hepatic Disease.
- Cardiac complications as initial manifestation of pheochromocytoma: frequency, outcome, and predictors.
- Growth speed of sporadic pheochromocytoma.
- Rescue of a pathogenic mutant human glucagon receptor by pharmacological chaperones.
- Small pheochromocytomas: significance, diagnosis, and outcome.
- Novel Syndrome of four-limb proximal fragility fractures associated with HIV infection, cholestatic liver failure, and histiocytic infiltration of bone marrow.
- Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors.
- Internal jugular thrombus revealed by fine-needle aspiration to be metastatic papillary Thyroid carcinoma.
- Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice.
- Adrenal Cushing syndrome shortly after Adrenal insufficiency.
- A natural inactivating mutant of human glucagon receptor exhibits multiple abnormalities in processing and signaling.
- Diagnosis and management of pheochromocytoma in an academic hospital 3 years after formation of a pheochromocytoma interest group.
- Bilateral pheochromocytoma manifesting as acute shortness of breath after job loss.
- Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia Type 1.
- Pathologic pancreatic endocrine cell hyperplasia.
- Morphologic features of carcinoid heart Disease as assessed by three-dimensional transesophageal echocardiography.
- Radiotherapy: Radioactive somatostatin analog therapy against carcinoids.
- Spared Adrenals: transient florid ectopic Cushing syndrome associated with necrosis of metastatic carcinoid.
- Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis.
- Pathogenesis of pituitary tumors.
- Left ventricular thrombus and embolic stroke caused by a functional paraganglioma.
- Pancreatic neuroendocrine tumors: presentation, management, and outcomes.
- Metabolic and receptor imaging in patients with neuroendocrine tumors: comparison of fludeoxyglucose-positron emission tomography and computed tomography with indium i...
- Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor.
- Ordering pattern and performance of biochemical tests for diagnosing pheochromocytoma between 2000 and 2008.
- Diminished pancreatic beta-cell mass in securin-null mice is caused by beta-cell apoptosis and senescence.
- Diagnosis and treatment of pheochromocytoma in an academic hospital from 1997 to 2007.
- Pheochromocytoma in patients suspected of harboring Adrenal metastasis: management and clinical predictors.
- Natural history of a sporadic pheochromocytoma.
- Nesidioblastosis and hyperplasia of alpha cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas: review of the literature.
- Anti-aging therapy with human growth hormone associated with metastatic colon Cancer in a patient with Crohn's colitis.
- Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth.
- Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas.
- Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells.
- Cyclin-dependent kinase inhibitor gene polymorphisms in pituitary gigantism.
- Dietary galactose inhibits GDF-9 mediated follicular development in the rat ovary.
- A novel molecular marker of pituitary tumor transforming gene involves in a rat liver regeneration.
- Pituitary tumor transforming gene: an update.
- Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells.
- Functional association of somatostatin receptor subTypes 2 and 5 in inhibiting human growth hormone secretion.
- The cell adhesion molecules N-cadherin and neural cell adhesion molecule regulate human growth hormone: a novel mechanism for regulating pituitary hormone secretion.
- Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and Diabetes.
- Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
- Seasonal variations of plasma normetanephrine levels in Los Angeles.
- Cardiac abnormalities associated with pheochromocytoma and other Adrenal tumors.
Conditions Treated
- Adrenal Insufficiency
- Cushing's Syndrome
- Diabetes Type 1
- Diabetes Type 2
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Cedars-Sinai Medical Center -
Peking Union Medical College
Hospital
-
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER | 1154493674 | |
| NPPES Provider LastName | YU | |
| NPPES Provider FirstName | RUN | |
| NPPES Provider ZIPCode | 900510717 | |
| NPPES Provider State | CA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 165.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1154493674 |
| Last Name Of The Provider | YU |
| First Name Of The Provider | RUN |
| View All |
Similar Doctors
|
|
Dr. Vivien Bonert, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicole M. Tyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danny Petrasek, MD |
|
|
Dr. Magdalena Uhart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Basil Rapoport, MB CHB
This Doctor is OpenDoctor Recommended.
|